151 related articles for article (PubMed ID: 3531421)
1. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.
Bennett JM; Cain KC; Glick JH; Johnson GJ; Ezdinli E; O'Connell MJ
J Clin Oncol; 1986 Oct; 4(10):1462-9. PubMed ID: 3531421
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow biopsy for the staging of non-Hodgkin's lymphoma: bilateral or unilateral trephine biopsy?
Luoni M; Declich P; De Paoli Af1p4 ; Fava S; Marinoni P; Montalbetti L; Sangalli G; Sciuccati P; Tocci A; Tosi A
Tumori; 1995; 81(6):410-3. PubMed ID: 8804465
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphoma in childhood--five years survey in VGH-Taipei.
Wang JH; Chang TK; Hsieh YL; Hwang BT
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Oct; 44(4):249-55. PubMed ID: 2634460
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
6. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.
Patte C; Philip T; Rodary C; Bernard A; Zucker JM; Bernard JL; Robert A; Rialland X; Benz-Lemoine E; Demeocq F
J Clin Oncol; 1986 Aug; 4(8):1219-26. PubMed ID: 3525767
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow biopsy in non-Hodgkin's lymphoma: experience with 259 samples].
Hernández Nieto L; Hernández García MT; González Brito G; Brito Barroso ML; Marsa Vila L; Chavez MI
Sangre (Barc); 1989 Aug; 34(4):271-7. PubMed ID: 2772780
[TBL] [Abstract][Full Text] [Related]
8. Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
Waits TM; Greco FA; Greer JP; Johnson DH; Wolff SN; Stein RS; McMaster ML; Hainsworth JD
J Clin Oncol; 1993 May; 11(5):943-9. PubMed ID: 7683712
[TBL] [Abstract][Full Text] [Related]
9. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
[TBL] [Abstract][Full Text] [Related]
11. Follicular non-Hodgkin's lymphoma in Hong Kong Chinese: a retrospective analysis.
Liang R; Todd D; Chan TK; Ng RP; Choy D; Loke SL; Ho FC
Hematol Oncol; 1988; 6(1):29-37. PubMed ID: 3343027
[TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin's lymphoma in children.
Pinkel D; Johnson W; Aur RJ
Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?
Johnson GJ; Oken MM; Anderson JR; O'Connell MJ; Glick JH
Lancet; 1984 Sep; 2(8404):685-7. PubMed ID: 6147703
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for advanced diffuse large cell lymphoma. The adverse effects of bone marrow invasion, gastrointestinal tract involvement or high bulk disease.
Jacobs P; King HS; Dent DM
Haematologia (Budap); 1990; 23(1):41-7. PubMed ID: 1697822
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic analysis of 125 cases of non-Hodgkin's lymphoma.
Liu L; Zhang M; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):547-50. PubMed ID: 18549626
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in low-grade lymphoma].
Gandarillas MA; Conde E; Mazorra F; Cuadrado MA; Baro J; Garijo J; Recio M; Richard C; Iriondo A; Zubizarreta A
Sangre (Barc); 1998 Jun; 43(3):185-90. PubMed ID: 9741223
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Hagenbeek A; Carde P; Meerwaldt JH; Somers R; Thomas J; De Bock R; Raemaekers JM; van Hoof A; De Wolf-Peeters C; van Glabbeke M
J Clin Oncol; 1998 Jan; 16(1):41-7. PubMed ID: 9440721
[TBL] [Abstract][Full Text] [Related]
18. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
Lambertenghi Deliliers G; Butti C; Baldini L; Ceriani A; Lombardi F; Luoni M; Montalbetti L; Pavia G; Pinotti G; Pogliani E
Haematologica; 1995; 80(4):318-24. PubMed ID: 7590500
[TBL] [Abstract][Full Text] [Related]
19. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look.
Ebie N; Loew JM; Gregory SA
Hematol Pathol; 1989; 3(1):29-33. PubMed ID: 2745358
[TBL] [Abstract][Full Text] [Related]
20. Sequential staging in non-Hodgkin's lymphoma.
Chabner BA; Johnson RE; DeVita VT; Canellos GP; Hubbard SP; Johnson SK; Young RC
Cancer Treat Rep; 1977 Sep; 61(6):993-7. PubMed ID: 902262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
